Gentium Provides Update on MAA Process for Defibrotide in Europe
Dec 29, 2011
Results From Gentium's Treatment IND for Defibrotide Presented at the American Society of Hematology Annual Meeting
Dec 12, 2011
Gentium Announces Changes to Board of Directors
Dec 08, 2011
Updated Results from Gentium’s Treatment IND for Defibrotide to be Presented at the American Society of Hematology
Nov 29, 2011
Gentium Announces Establishment of Commercial Infrastructure and Appointment of Commercial Leadership Team
Nov 22, 2011
Gentium Provides Update on MAA Process for Defibrotide in Europe
Oct 20, 2011
Gentium Announces Management Change
Oct 04, 2011
Gentium Withdraws New Drug Application for Defibrotide
Aug 17, 2011
Gentium Announces NDA Submission for Defibrotide
Jul 06, 2011
Gentium Signs License and Distribution Agreement for Defibrotide with Medison Pharma Ltd. in Israel and the Palestinian Authority
Jun 21, 2011
Gentium Appoints GEN Ilac as Exclusive Distributor of Defibrotide in Turkey
Jun 16, 2011
Gentium Appoints Link Pharmaceuticals as Exclusive Distributor of Defibrotide in Australia and New Zealand
Jun 15, 2011
Gentium Announces MAA for Defibrotide Accepted by EMA and will be Reviewed by CHMP under Accelerated Assessment
Jun 01, 2011
Gentium Announces Submission of a Marketing Authorization Application for Defibrotide to the European Medicines Agency
May 10, 2011
Gentium Hosts Symposium on Defibrotide at EBMT Annual Meeting and Sponsors Basic Science Award
Apr 05, 2011
Gentium Appoints Adrian Haigh as Senior Vice President of Commercial Operations
Mar 03, 2011
Gentium Announces Completion of Preclinical and Clinical Studies for Defibrotide
Feb 08, 2011